Skip to main content
. Author manuscript; available in PMC: 2011 Feb 8.
Published in final edited form as: J Immunol. 2008 Apr 15;180(8):5653–5661. doi: 10.4049/jimmunol.180.8.5653

FIGURE 2.

FIGURE 2

The effect of protein synthesis inhibitor, cycloheximide (CHX) on IL-1β-induced increase in MLCK protein expression and drop in Caco-2 TER. A, Cycloheximide (5 μM) pretreatment prevented the IL-1β-induced up-regulation in MLCK protein expression as assessed by Western blot analysis. B, Cycloheximide prevented the IL-1β-induced drop in Caco-2 TER (means ± SE, n = 4). *, p < 0.001 vs control; **, p < 0.001 vs IL-1β treatment.